SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-084060
Filing Date
2022-03-25
Accepted
2022-03-24 17:45:01
Documents
4
Period of Report
2022-03-24

Document Format Files

Seq Description Document Type Size
1 6-K d303068d6k.htm 6-K 10344
2 EX-99.1 d303068dex991.htm EX-99.1 100345
3 GRAPHIC g303068g44g30.jpg GRAPHIC 6568
4 GRAPHIC g303068g66b53.jpg GRAPHIC 5085
  Complete submission text file 0001193125-22-084060.txt   128205
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 22767698
SIC: 2834 Pharmaceutical Preparations